Correlations between SUVmax and Expression of GLUT1 and Growth Factors Inducing Lymphangiogenesis

Academic Radiology

Volumn 19, Issue 4, 2012, Pages 420-426

  Tian, Mohan ^a   Yu, Lijuan ^a   Zhang, Yafang ^a   Gao, Xuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

18F FDG PET CT; Colorectal carcinoma; Lymph node metastasis; Lymphangiogenetic factor; SUVmax

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; MEGLUMINE DIATRIZOATE; SCATTER FACTOR; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG TUMOR LEVEL; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; OPTICAL DENSITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863391889     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.12.006     Document Type: Article

References (34)

1. Gu J., Yamamoto H., Fukunaga H., et al. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 2006, 51:2198-2205.
2. 18F-FDG in colorectal tumors. J Nucl Med 2008, 49:1238-1244.
3. Fan Y.X., Shi W.M., Li J., et al. Relationship between fluorodeoxyglucose uptake and vascular endothelial growth factor in early-stage nasophygeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29:2067-2069. [article in Chinese].
4. Takenaka T., Yano T., Ito K., et al. Biological significance of the maximum standardized uptake values on positron emission tomography in non-small cell lung cancer. J Surg Oncol 2009, 100:688-692.
5. Kaira K., Oriuchi N., Shimizu K., et al. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci 2009, 100:753-758.
6. 18F-FDG PET analysis of schwannoma: increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors. Skeletal Radiol 2009, 38:261-266.
7. Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005, 5:735-743.
8. Cao Y., Linden P., Farnebo J., et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1998, 95:14389-14394.
9. Marconcini L., Marchio S., Morbidelli L., et al. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci U S A 1999, 96:9671-9676.
10. Bjorndahl M.A., Cao R., Burton J.B., et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 2005, 65:9261-9268.
11. Chang L., Kaipainen A., Folkman J. Lymphangiogenesis new mechanisms. Ann N Y Acad Sci 2002, 979:111-119.
12. Hong Y.K., Lange-Asschenfeldt B., Velasco P., et al. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J 2004, 18:1111-1113.
13. Nagy J.A., Vasile E., Feng D., et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002, 196:1497-1506.
14. Cursiefen C., Chen L., Borges L.P., et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004, 113:1040-1050.
15. Cao R., Björndahl M.A., Religa P., et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004, 6:333-345.
16. Tammela T., Saaristo A., Lohela M., et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 2005, 105:4642-4648.
17. Joukov V., Pajusola K., Kaipainen A., et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15:290-298.
18. Kajiya K., Hirakawa S., Ma B., et al. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 2005, 24:2885-2895.
19. Sarntinoranont M., Rooney F., Ferrari M. Interstitial stress and fluid pressure within a growing tumor. Ann Biomed Eng 2003, 31:327-335.
20. Dorević G., Matusan-Ilijas K., Babarović E., et al. Hypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma. J Exp Clin Cancer Res 2009, 28:40-47.
21. Zuo S., Ji Y., Wang J., et al. Expression and clinical implication of HIF-1alpha and VEGF-C in non-small cell lung cancer. J Huazhong Univ Sci Technolog Med Sci 2008, 28:674-676.
22. Liang X., Yang D., Hu J., et al. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma. Anticancer Res 2008, 28:1659-1666.
23. Favier J., Lapointe S., Maliba R., et al. HIF2 alpha reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma. BMC Cancer 2007, 26:139-143.
24. Yamada Y., Nezu J., Shimane M., et al. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 1997, 42:483-488.
25. Ong L.C., Jin Y., Song I.C., et al. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II. Acta Radiol 2008, 49:1145-1153.
26. Li S.J., Guo W., Ren G.X., et al. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofac Surg 2008, 46:180-186.
27. Kurokawa T., Yoshida Y., Kawahara K., et al. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary. Int J Cancer 2004, 109:926-932.
28. Paudyal B., Paudyal P., Oriuchi N., et al. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma. Int J Oncol 2008, 33:1047-1054.
29. Burgman P., Odonoghue J.A., Humm J.L., et al. Hypoxia-induced increase in FDG uptake in MCF7 cells. J Nucl Med 2001, 42:170-175.
30. Lidgren A., Bergh A., Grankvist K., et al. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha. BJU Int 2008, 101:480-484.
31. Wincewicz A., Sulkowska M., Koda M., et al. Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer. Pathol Oncol Res 2007, 13:15-20.
32. Allen J.W., Johnson R.S., Bhatia S.N. Hypoxic inhibition of 3-methylcholanthrene-induced CYP1A1 expression is independent of HIF-1alpha. Toxicol Lett 2005, 155:151-159.
33. Airley R.E., Mobasheri A. Hypoxic regulation of glucose transport. metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007, 53:233-256.
34. Pedersen M.W., Holm S., Lund E.L., et al. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia 2001, 3:80-87.